Information about Notification for Subscription of Diamyd shares upon exercise of warrant DIAM TO 2B

Notification for subscription of shares supported by the warrant Diamyd Medical TO 2B shall take place between March 16 and April 17, 2009. If the warrant is not exercised within the period stated above, it will expire without value.

In April 2008 Diamyd Medical issued 991,000 subscription warrants in connection with a directed placement. The warrants are traded on the market place First North under the name DIAM TO 2B. The last day to trade the options on First North is April 8, 2009. Holding of one (1) warrant entitles the owner to subscribe to one (1) new series B share in Diamyd Medical AB at a price of SEK 100 per share during the period March 16 to April 17, 2009. The Notification form for subscription of shares supported by the warrant DIAM TO 2B can be downloaded from the Company’s website at www.diamyd.com, or be ordered by phone from NASDAQ OMX at +46 (0)8-405 7678. Funds are due upon submission of the Notification form. All instructions can be found on the Notification form. Please note that only holders of warrants registered in securities accounts (VP accounts) can subscribe for shares using this notification form. If your options are registered in the name of a trustee, please contact your trustee. Interim shares will be provided once NASDAQ OMX has received both the notification and the subscription funds. The interim shares will not be listed for trading. The new shares are expected to be available for trading one to two weeks after the final subscription date of April 17. For administrative questions about the subscription procedure, please contact: Elinor Rudheim NASDAQ OMX, Corporate Finance Administration, Transactions Services Nordics Direct: +46 8 405 7678 elinor.rudheim@nasdaqomx.com

Tags: